MEM ASX Chart
Snapshot
Memphasys Limited (MEM) specialises in reproductive biotechnology for commercial applications. Reproductive biotechnology products in development include medical devices, in vitro diagnostics, and new proprietary media. The Company's patented bio separation technology, utilised by the Company's product, the Felix System, combines electrophoresis with proprietary size exclusion membranes to separate the most viable sperm cells for human artificial reproduction.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2025 YTD | |
1 Year | |
vs Sector (1yr) | -27.59% |
vs ASX 200 (1yr) | -31.84% |
Announcements
Corporate Overview
Corporate Details
Head Office | Homebush NSW 2140 |
Website | www.memphasys.com |
Registry | BoardRoom |
Auditor | Pitcher Partners Sydney |
Date Listed | 14 May 2007 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
29/08/2025 | Report (Prelim) |
17/09/2025 | Report (Annual) |
27/02/2026 | Report (Interim) |
Former Company Names
- Nusep Holdings Ltd (NSP), 05/07/2016
- NuSep Ltd (NSP), 3/11/2010
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
MEM directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of MEM directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Andrew Ernest Goodall | 09/09/2024 | 138,022,157 | 9.55 |
Alison Coutts | 09/09/2024 | 93,847,375 | 6.49 |
Peters Investments Pty Ltd | 09/09/2024 | 261,564,791 | 18.10 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $0.007 | 28 June |
2023 | $0.014 | 30 June |
2022 | $0.04 | 30 June |
2021 | $0.064 | 30 June |
2020 | $0.058 | 30 June |
2019 | $0.025 | 28 June |
2018 | $0.001 | 29 June |
2017 | $0.001 | 30 June |
2016 | $0.006 | 30 June |
2015 | $0.03 | 30 June |
2014 | $0.061 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.